These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17295588)

  • 1. Expectancy and pharmacology influence the subjective effects of nicotine in a balanced-placebo design.
    Kelemen WL; Kaighobadi F
    Exp Clin Psychopharmacol; 2007 Feb; 15(1):93-101. PubMed ID: 17295588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition.
    Dawkins L; Turner J; Hasna S; Soar K
    Addict Behav; 2012 Aug; 37(8):970-3. PubMed ID: 22503574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of nicotine stimulus and response expectancies on male and female smokers' responses to nicotine-free electronic cigarettes.
    Copp SR; Collins JL; Dar R; Barrett SP
    Addict Behav; 2015 Jan; 40():144-7. PubMed ID: 25261789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
    Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; MacKinnon SV; Sirota AD; Kaplan GB
    Exp Clin Psychopharmacol; 2007 Feb; 15(1):81-92. PubMed ID: 17295587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of nicotine dose and nicotine dose expectancy on the cognitive and subjective effects of cigarette smoking.
    Juliano LM; Fucito LM; Harrell PT
    Exp Clin Psychopharmacol; 2011 Apr; 19(2):105-15. PubMed ID: 21463067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers.
    Poltavski DV; Petros T
    Physiol Behav; 2005 Jan; 83(5):833-43. PubMed ID: 15639169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial.
    Bullen C; McRobbie H; Thornley S; Glover M; Lin R; Laugesen M
    Tob Control; 2010 Apr; 19(2):98-103. PubMed ID: 20378585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower but not higher doses of transdermal nicotine facilitate cognitive performance in smokers on gender non-preferred tasks.
    Poltavski DV; Petros TV; Holm JE
    Pharmacol Biochem Behav; 2012 Sep; 102(3):423-33. PubMed ID: 22691869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of nicotine content information in smokers' subjective responses to nicotine and placebo inhalers.
    Darredeau C; Barrett SP
    Hum Psychopharmacol; 2010 Nov; 25(7-8):577-81. PubMed ID: 21312293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray.
    Myers CS; Taylor RC; Moolchan ET; Heishman SJ
    Neuropsychopharmacology; 2008 Feb; 33(3):588-98. PubMed ID: 17443125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological, sensorimotor, and expectancy effects on tobacco withdrawal: a preliminary study.
    Guillot CR; Stone MD; Geary BA; Kirkpatrick MG; Tidey JW; Cook JW; Leventhal AM
    Hum Psychopharmacol; 2015 Sep; 30(5):364-71. PubMed ID: 26010521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of nicotine content information on subjective and behavioural responses to nicotine-containing and denicotinized cigarettes.
    Darredeau C; Stewart SH; Barrett SP
    Behav Pharmacol; 2013 Aug; 24(4):291-7. PubMed ID: 23787293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers.
    Sobel BF; Sigmon SC; Griffiths RR
    Neuropsychopharmacology; 2004 May; 29(5):991-1003. PubMed ID: 15010695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cigarettes on memory search and subjective ratings.
    West R; Hack S
    Pharmacol Biochem Behav; 1991 Feb; 38(2):281-6. PubMed ID: 2057498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans.
    Sofuoglu M; Waters AJ; Mooney M; O'Malley SS
    Pharmacol Biochem Behav; 2009 Mar; 92(1):135-40. PubMed ID: 19041336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days.
    Donny EC; Houtsmuller E; Stitzer ML
    Addiction; 2007 Feb; 102(2):324-34. PubMed ID: 17222288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes.
    Brauer LH; Cramblett MJ; Paxton DA; Rose JE
    Psychopharmacology (Berl); 2001 Dec; 159(1):31-7. PubMed ID: 11797066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of a 24-hour nicotine patch and a 16-hour nicotine patch on smoking urges and sleep.
    Aubin HJ; Luthringer R; Demazières A; Dupont C; Lagrue G
    Nicotine Tob Res; 2006 Apr; 8(2):193-201. PubMed ID: 16766412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.